Tumor necrosis facto superfamily receptor TWEAKR
2026-01-19
Tumor necrosis factor receptor superfamily member 12A (TNFRSF12A), also known as fibroblast growth factor-induced early response protein 14 (FN14), TWEAKR, or CD266, is the TNFSF12...
The positive regulator of complement CFP
2026-01-13
CFP (Properdin) is a positive regulator of the complement alternative pathway (AP). It binds to and stabilizes the C3 and C5 convertase complex, inhibiting CFI-CFH-mediated degrada...
Carbonic anhydrase CA9
2026-01-13
Tumor hypoxia remains a significant challenge for the effective treatment of most cancers. Tumor cells in hypoxic environments often exhibit strong resistance to most treatment mod...
Anti-Müllerian Hormone Signaling Maintains Circadian Homeostasis in Zebrafish
2026-01-12
Service SupportMabnus Biotech provides services for recombinant protein expression, antibody preparation, molecular docking, and SPR detection.BackgroundThe biological clock coordi...
Tyrosine protein kinase receptor AXL
2026-01-09
Tyrosine protein kinase receptor (AXL/UFO) is a member of the TAM receptor family. It transduces signals from the extracellular matrix to the cytoplasm by binding to the growth fac...
Complement Cascade Initiator C1s
2026-01-08
C1s are an essential protein in the complement system and a component of the complement C1 complex. C1s are the initiator of the classical complement activation pathway. When the C...
Tumor immune escape therapy target HLAG
2026-01-07
Human leukocyte antigen-G (HLA-G) is an atypical major histocompatibility complex (MHC) class I molecule. HLA-G is typically expressed at the maternal-fetal border and in certain i...